Toss Up for Second-Line IBD Tx; Screening for Esophageal Cancer; 100 Colon Polyps

Effectiveness of vedolizumab (Entyvio) and tofacitinib (Xeljanz) for ulcerative colitis or vedolizumab and ustekinumab (Stelara) for Crohn’s disease did not significantly differ among patients who failed on tumor necrosis factor inhibitors. (BMC Gastroenterology)

After a food handler at a West Hollywood juice bar tested positive for hepatitis A, Los Angeles county officials are looking to identify any exposed customers. (ABC 7 Los Angeles)

A cost-effectiveness model found that optimal screening for esophageal adenocarcinoma varied by race and sex — screening women was not cost-effective and could lead to harm among Black women, while white men with gastroesophageal reflux disease symptoms potentially need more intense screening. (Gastroenterology)

Comprehensive data are lacking on patients with both primary biliary cholangitis and hepatocellular carcinoma, but an Italian study found they tended to be older with cirrhosis but well-preserved liver function, and curative treatment was often feasible. (Digestive and Liver Disease)

Metabolic dysfunction-related liver disease, non-alcoholic steatohepatitis, and higher scores on the fatty liver index or fibrosis-4 index were linked to a greater risk of cancer incidence and death, a study from Scotland found. (BMJ Open Gastroenterology)

For the first time at Michigan Medicine, a liver transplant was performed by an all-woman team. (Michigan Medicine Headlines)

Stanford Children’s Health announced the launch of its new Center for Pediatric Inflammatory Bowel Disease and Celiac Disease after receiving $70 million from an anonymous donor. (Stanford Report)

Bluegrass musician Mark Newton received a liver transplant after being diagnosed with hepatitis C and cirrhosis. (Bluegrass Today)

Surgeons at the Cleveland Clinic had to remove a man’s entire colon after over 100 potentially cancerous polyps were found; he’s now urging others not to ignore symptoms. (Click on Detroit)